Van Duesterberg

Hold up, you need to know about Van Duesterberg, this guy’s a total badass in biotech and health tech. So, he jumped into the startup scene with Nutrigene back in W18 when Y Combinator threw their winter batch, that’s when things started to get real. But his story’s way deeper than just that.

Van’s a legit biophysicist and epigeneticist, basically, he’s all about understanding what makes us *us* at the genetic level and how to tweak it for better health. Before he co-founded Nutrigene, he was deep in the trenches at places like Stanford, NIH, and even Singularity University, yeah, he’s been around the smartest minds in biotech and research. Those gigs tell you he’s not some random, he’s legit, driven, and super passionate about pushing the boundaries of health tech.

And he’s not just sitting on his ass researching. He’s been a biotech R&D consultant, which means he’s out there helping other companies innovate and crush it. Plus, he’s worked with Treasure8, Key Labs, Manylabs, and Premiere Oncology, all top players doing cool stuff in biotech, personalized nutrition, and even clinical translation. Basically, Van’s been involved in everything from modern research to startup hustle to real-world health solutions.

What does that say about him? This guy’s motivation is raw, he’s genuinely trying to solve big health problems, make a difference, and not just chase the next shiny thing. His process shows he’s all about pushing the envelope, jumping into new tech, exploring the weird edges of biology, and turning that into startups that could change lives. Starting Nutrigene wasn’t just a random move; it was part of a bigger mission to innovate how we understand and improve health at the genetic level.

Long story short, Van’s the real deal. He’s a scientist who jumped into startups, turned his research into products, and kept pushing forward. He’s the kind of guy who sees a problem, dives deep into the science, and then figures out how to fix it for real. That’s why he’s important, he’s not just playing around in biotech; he’s building the future of health tech. No Cap.